ArticleCurrent zoology2026
Global venomous snake redistribution and snakebite risk under climate change.
Article in Current zoology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictive Modeling of Localized Mobile App to Improve Snakebite Management in Ghana.PLoS neglected tropical diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Climate change is reshaping the global distribution of venomous snakes, with important implications for public health. Snakebite envenoming is estimated to cause approximately 63,400 deaths annually, mostly in tropical and developing countries. However, few studies have comprehensively assessed the future global patterns of envenomation risk, particularly across venom types with differing clinical and ecological characteristics. In this study, we modeled the current and future distributions of 193 medically important venomous snake species (neurotoxic and hemotoxic) under 4 climate change scenarios through 2100. We assessed 3 indices to quantify snakebite risks: the Venom Richness Index (VRI) for species-specific venom diversity, the Snakebite Range Expansion Index (SREI) to capture range expansion or contraction, and the Venom Overlap Index (VOI) for geographic co-occurrence of venom types. We found that snakebite risk is projected to increase in temperate and cold regions under high-emissions scenarios, with VRI and SREI increasing in areas such as North America, Europe, and East Asia. In contrast, VRI and SREI are projected to decline across parts of tropical Africa, India, and southern China. VRI transitions are projected to expand in northern Mexico, Brazil, Spain, southwestern China, and southern Australia, increasing the potential for diagnostic uncertainty and treatment complexity. VOI is expected to rise in highly populated but poorly urbanized regions, highlighting the vulnerability of developing countries with limited infrastructure. These spatial and venom-specific shifts underscore the need for regionally tailored antivenom strategies, improved diagnostics, and high-resolution risk forecasting to mitigate the future burden of snakebite under global change.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.